Jill Carroll has bought stock on 2 days since Feb 2022
Director at Avalyn Pharma Inc., and 1 other company
SEC CIK 0001598542 · Filings on SEC.gov ↗
Jill Carroll's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
6 filings since Feb 2022, newest first
About Jill Carroll
Jill Carroll is an Independent Director at Avalyn Pharma Inc. (AVLN), a clinical-stage biopharmaceutical company developing inhaled therapies for rare respiratory diseases such as pulmonary fibrosis and interstitial lung diseases (ILDs).( She recently signed SEC filings for the company as a Director on April 30, 2026.(
Jill Carroll is a Partner at SR One, a venture capital firm, where she originally joined in 2011 and manages key investments including Arcellx (ACLX), Odyssey, and Avalyn Pharma.( She also serves on the board of Arcellx, Inc.( Previously, she worked in strategy consulting and biotech corporate development at Dynavax Technologies (NASDAQ: DVAX). Carroll holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.